Retinal Update and Biologics in Ocular Inflammation
Date: 29/10/2019
Venue: Newcastle Club, 40 Newcomen St Newcastle NSW 2300, NSW, 2300
Provider: Dr Anthony Dunlop
Contact: Anthony Dunlop, [E] anthony@drsdunlop.com.au, [P] 0407704693
Learning Objectives
- Recognise that treat and extend treatment protocols can tolerate subretinal fluid in wet AMD without significant loss of vision.
- Recognise that laser remains a useful option for some proliferative diabetic retinopathy patients
- Recognise that with good vision, a diabetic macula oedema patient may do well without intervention as long as followup can be maintained
- Recognise the place for biologics in the treatment paradigm of uveitis
- Recognise systemic diseases which may use biologics which typically may precipitate ocular side effects
- Recognise how common the use of biologics has become
Max points awarded: 6.00
Session Information
| Name |
|---|
| Retinal Update and Biologics in Ocular Inflammation |
| Activity Type |
| Face to Face with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 6.00 |